GMNN2CD: identification of circRNA-disease associations based on variational inference and graph Markov neural

Mengting Niu1,2, Quan Zou1,2, Chunyu Wang3

  • 1Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, China.

Insights

This study introduces GMNN2CD, a computational method using graph Markov neural networks to predict circular RNA-disease associations. GMNN2CD accurately identifies potential links, aiding disease research and treatment development.

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their crucial roles in various diseases.
  • Understanding circRNA-disease relationships is vital for disease pathogenesis and therapeutic strategies.
  • Traditional biotechnological methods for identifying these associations are often inefficient.

Purpose of the Study:

  • To develop an efficient computational method for predicting novel circRNA-disease associations.
  • To leverage graph Markov neural networks (GMNN) for enhanced association prediction.

Main Methods:

  • GMNN2CD utilizes verified circRNA-disease associations to compute semantic and Gaussian interactive profile kernel similarities.
  • A fusion feature variational map autoencoder learns deep features, while a label propagation map autoencoder propagates known associations.
  • Variational inference and GMNN alternate training optimize high-dimensional feature extraction from low-dimensional representations.

Main Results:

  • GMNN2CD demonstrated superior performance compared to state-of-the-art methods across five benchmark datasets via 5-fold cross-validation.
  • Case studies confirmed GMNN2CD's capability in detecting potential circRNA-disease associations.
  • The method effectively predicts unknown circRNA-disease associations.

Conclusions:

  • GMNN2CD offers an efficient and accurate computational approach for circRNA-disease association prediction.
  • This method can significantly contribute to understanding disease mechanisms and identifying therapeutic targets.
  • The developed tool and data are publicly available for further research.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K